Primary Role for Adherent Leukocytes in Sickle Cell Vascular Occlusion: A New Paradigm von Turhan, Aslihan, Weiss, Linnea A., Mohandas, Narla, Coller, Barry S., Frenette, Paul S.

Volltext

Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leuko... von Turhan, Aslihan, Jenab, Pegah, Bruhns, Pierre, Ravetch, Jeffrey V., Coller, Barry S., Frenette, Paul S.

Volltext

Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene? von Coller, Barry S

Volltext

Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics von Xiao, Tsan, Takagi, Junichi, Coller, Barry S., Wang, Jia-Huai, Springer, Timothy A.

Volltext

Platelets and Thrombolytic Therapy von Coller, Barry S

Volltext

Analysis of GPIIb/IIIa Receptor Number by Quantification of 7E3 Binding to Human Platelets von Wagner, Carrie L., Mascelli, Mary A., Neblock, Donald S., Weisman, Harlan F., Coller, Barry S., Jordan, Robert E.

Volltext

Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions von Coller, Barry S.

Volltext

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics von Coller, B S

Volltext

Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease von Manci, Elizabeth A., Hillery, Cheryl A., Bodian, Carol A., Zhang, Zheng G., Lutty, Gerard A., Coller, Barry S.

Volltext

The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocard... von Rikken, AOF, Bor, WL, Zheng, KL, Gibson, CM, Granger, CB, Bentur, O, Lobatto, R, Postma, S, Coller, BS, Van ’T Hof, AWJ, Ten Berg, JM

Volltext

Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy von COLLER, B. S

Volltext

Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in Six New York Community Health Centers von Piper Jenks, N, Pardos de la Gandara, M, D’Orazio, B.M, Correa da Rosa, J, Kost, R.G, Khalida, C, Vasquez, K.S, Coffran, C, Pastagia, M, Evering, T.H, Parola, C, Urban, T, Salvato, S, Barsanti, F, Coller, B.S, Tobin, J.N., PhD

Volltext

Potential non-glycoprotein IIb/IIIa effects of abciximab von Coller, Barry S.

Volltext

Rapid platelet-function assay: An automated and quantitative cartridge-based method von SMITH, J. W, STEINHUBL, S. R, LINCOFF, A. M, COLEMAN, J. C, LEE, T. T, HILLMAN, R. S, COLLER, B. S

Volltext

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on... von Reverter, J C, Béguin, S, Kessels, H, Kumar, R, Hemker, H C, Coller, B S

Volltext

Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor von BEER, J. H, SPRINGER, K. T, COLLER, B. S

Volltext

Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1... von Smyth, S S, Reis, E D, Zhang, W, Fallon, J T, Gordon, R E, Coller, B S

Volltext

Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms von Smyth, S S, Reis, E D, Väänänen, H, Zhang, W, Coller, B S

Volltext

Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embol... von LI ZHANG, ZHENG GANG ZHANG, RUILAN ZHANG, MORRIS, Daniel, MEI LU, COLLER, Barry S, CHOPP, Michael

Volltext

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics von Coller, B S

Volltext